The rising burden of antimicrobial resistance and increasing infectious disease outbreaks,
including the recent COVID-19 pandemic, has led to a growing demand for the development …

Clostridioides difficile is an enteric pathogen that can cause a range of illnesses from mild
diarrhea to pseudomembranous colitis and even death. This pathogen often takes …

Clostridioides difficile, the causative agent of antibiotic-associated diarrhea and
pseudomembranous colitis, has emerged as a major enteric pathogen in recent years …

Background Clostridium difficile infection (CDI) is a debilitating nosocomial infection. C.
difficile produces toxins A and B, which cause inflammation. Existing therapies have issues …

Clostridioides difficile is a major cause of nosocomial infections, often associated with
individuals who have gut dysbiosis from previous antibiotic therapies. C. difficile infections …

The opportunistic pathogen, Clostridioides difficile owes its extreme pathogenicity for its
ability to develop antibiotic resistance and recurrent infections. The current antibiotics used …

Clostridioides difficile is a pathogenic bacterium responsible for antibiotic-associated
diarrhea globally. The pathogenesis of this bacterium is due to its virulence toxins, which …

Background Microbiota manipulation through preoperative probiotic supplementation to
reduce surgical site infection has shown promising results in recent years. However, the …